Select Guide Rating

• Section 1 Glaucoma in the World1. Prevalence and Geographic Variations2. Screening for GlaucomaSection 2 Pathogenesis3. Aqueous Humor Dynamics and Intraocular Pressure Elevation4. Pathogenesis of Glaucomatous Optic Neuropathy5. Mechanical Strain and Restructuring of the Optic Nerve Head6. Role of Vascular Blood Flow in the Pathogenesis of Glaucoma7. Metabolism, Ageing, and Glaucoma PathogenesisSection 3 Evaluation of Glaucoma8. Tonometry and Intraocular Pressure Fluctuation9. Visual Fields10. Long Term Follow-Up of Visual Fields11. Function-Specific Perimetry12. New Approaches to Perimetry13. Electrophysiology in Glaucoma Assessment14. Gonioscopy15. Ultrasound Biomicroscopy and Angle Imaging16. Angle Imaging: Anterior Segment Optical Coherence Tomography17. Corneal Biomechanics in Glaucoma18. Optic Disc Photography in Diagnosis of Glaucoma19. Optic Disc Imaging20. Retinal Nerve Fiber Layer Analysis21. Optical Coherence Tomography Angiography in Glaucoma Diagnosis (OCTA)22. Measuring Glaucoma Progression in Clinical Practice23. Genetics of Glaucoma24. Genetic EpidemiologySection 4 Types of Glaucoma25. Ocular Hypertension26. Primary Open-Angle Glaucoma27. Normal Tension Glaucoma28. Exfoliation Syndrome and Exfoliative Glaucoma29. Pigmentary Glaucoma30. Primary Angle-Closure Glaucoma31. Secondary Angle-Closure Glaucoma32. Neovascular Glaucoma33. Uveitic Glaucoma34. Glaucoma Secondary to Trauma35. Glaucoma and Intraocular Tumors36. Glaucoma in the Phakomatoses and Related Conditions37. Other Secondary Glaucomas38. Childhood GlaucomasSection 5 Principles of Management39. Management of Ocular Hypertension and Primary Open-angle Glaucoma40. An Overview of Angle-Closure Management41. Quality of Life42. Optimizing Patient Outcomes in Glaucoma: Effectiveness of Glaucoma Treatments on Quality of Life43. Ocular Hypotensive Medications: Adherence and Performance44. Outcomes - Goals of Treatment45. Benefit Versus RiskSection 6 Medical Therapy46. Prostagladin Analogues47. Beta-blockers48. Carbonic Anhydrase Inhibitors49. Alpha Agonists50. Rhokinase51. Parasympathomimetics52. Fixed Combination Therapies in Glaucoma53. Ocular Surface Disease and the Role of Preservatives in Glaucoma Medications54. Sustained delivery systems for Glaucoma Medications55. Marijuana and Glaucoma56. Management of Acute Intraocular Pressure RiseSection 7 Surgery: Introduction57. Laser as First Line Treatment58. Surgery as First Line Treatment59. The Trabecular Meshwork Outflow Pathways: Surgical AspectsSection 8 Laser Therapy60. Selective Laser Trabeculoplasty61. Peripheral Iridotomy for Angle-Closure Glaucoma62. Laser Peripheral IridoplastySection 9 Trabeculectomy63. Ophthalmic Anesthesia64. Trabeculectomy: Preoperative Evaluation and Management65. Trabeculectomy66. Wound Healing and Bleb Evaluation after Trabeculectomy67. Intraoperative Complications of Trabeculectomy68. Early Postoperative Increase in Intraocular Pressure69. Tenon’s Cyst Formation and Management70. Postoperative Shallow Anterior Chamber71. Aqueous Misdirection72. Choroidal Effusion and Hemorrhage73. Late Bleb Leaks and Complications Associated with Modulation of Wound Healing in Glaucoma Surgery74. Blebitis and Endophthalmitis75. Late Hypotony76. Late Failure of Filtering Bleb77. Cataract Following Trabeculectomy78. Trabeculectomy-related Corneal complicationsSection 10 Nonpenetrating Glaucoma Surgery79. Non-Penetrating Procedures - Principle and Mechanism of Function80. Deep Sclerectomy and Postoperative Management of Nonpenetrating Glaucoma Surgery81. Results of Nonpenetrating Glaucoma SurgerySection 11 Modulation of Wound Healing82. Risk factors for excess wound healing83. Modulation of Wound Healing84. Biological Drivers of Postoperative Scarring and Future Strategies85. Bleb Needling and EnhancementSection 12 Management of Co-Existing Cataract and Glaucoma86. Cataract Surgery in Open Angle Glaucoma87. The Role of Lens Extraction in Primary Angle Closure Glaucoma88. Goniosynechialysis89. Cataract Surgery in Patients with Functioning Filtering Blebs90. Combined Phaco and MIGS91. Combined Sugery: Phacotrabeculectomy92. Combined cataract extraction and glaucoma drainage implant surgerySection 13 Drainage Devices93. Preoperative Evaluation of Patients Undergoing Drainage Implant Surgery and Choice of Implant94. Glaucoma Drainage Implants - Surgical Technique95. Aqueous Shunts after Retinal Surgery96. Intraoperative Complications and Postoperative Complications97. Glaucoma Implants: Results from Clinical Trials98. Aqueous Shunts and the CorneaSection 14 Surgery for Congenital Glaucoma99. Goniotomy and Trabeculotomy100. Further Surgical Options in ChildrenSection 15 Procedures that Target the Ciliary Body101. Cyclodestructive Techniques102. Endophotocoagulation103. Complications of Cyclodestructive ProceduresSection 16 MIGS104. Canal Based Procedures105. Canal based Devices106. Suprachoroidal Space Based Procedures107. Subconjunctival Based MIGS ProceduresSection 17 New Developments in Glaucoma108. Neuroprotection, Neuroenhancement, and Neuroregeneration109. RGC replacement110. Big Data and Glaucoma111. Lifestyle Changes in Glaucoma112. Meditation and Alternative Therapies for Glaucoma113. Smartphone and Virtual Reality Devices in Glaucoma screening and detection114. Telemedicine and Glaucoma115. AI and Glaucoma